Whether the pathology is based on the molecular pathology report card or the immunocombination report card depends on the specific situation of the patient, and the immunocombination report card usually prevails. The molecular pathology report card can reflect the initial state of the disease, but due to the morphology of the tumor is close, so it is difficult to understand the specific situation of the tumor, then it is necessary to use the immuno-combination report card to make further judgments. Immunocombination tests are mainly performed on antigenic molecules by the specific binding of antibodies to antigenic components in the recognized tissues and cells. In most diseases, the antigens in the tissues and cells are not specific, so the results of immunohistochemical staining can be used to make a comprehensive determination of the specific tissue origin of the tumor and the direction of differentiation. Generally speaking, it is recommended to perform both molecular pathology and immuno-combination tests when performing pathological examinations, combining the results of multiple aspects to diagnose the disease, so as to avoid the situation of misdiagnosis.